Drug · DIN 02481359
VELTASSA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 9, 2020; first marketed March 9, 2020.
- Drug Identification Number (DIN)
- 02481359
- Company (DIN owner)
- Vifor Fresenius Medical Care Renal Pharma LtdSt Gallen, St Gallen, Switzerland
- Schedule
- Prescription
- Dosage form
- Powder For Suspension
- Route
- Oral
- Therapeutic class (ATC)
- Patiromer calcium V03AE09
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PATIROMER (PATIROMER SORBITEX CALCIUM) | 8.4 G | SACHET |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 3, 2018: NOC 21384New Drug Submission (NDS)
Other DINs named VELTASSA
- DIN 02481367 · Marketed
- DIN 02481375 · Approved